Shilpa Medicare executes transfer agreement with Shilpa Pharma Lifesciences
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Shilpa Medicare has executed business transfer agreement with Shilpa Pharma Lifesciences (Formerly known as Shilpa Corporate Holdings) the transferee company which is complete and effective from June 30, 2022. With effect from closing of the transaction, Shilpa Pharma Lifesciences, a wholly owned subsidiary of Shilpa Medicare shall operate the API (Active Pharmaceutical Ingredient) business.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
